AI
FULC icon

Alphabet Inc’s Fulcrum Therapeutics FULC Stock Holding History

Alphabet Inc’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,262
Closed -$161K – 29
2025
Q4 		$161K Hold
14,262
– – 0.01% 28
2025
Q3 		$131K Hold
14,262
– – 0.01% 36
2025
Q2 		$98.1K Hold
14,262
– – ﹤0.01% 35
2025
Q1 		$41.1K Hold
14,262
– – ﹤0.01% 40
2024
Q4 		$67.2K Hold
14,262
– – ﹤0.01% 37
2024
Q3 		$50.9K Hold
14,262
– – ﹤0.01% 40
2024
Q2 		$88.4K Hold
14,262
– – ﹤0.01% 39
2024
Q1 		$135K Hold
14,262
– – 0.01% 39
2023
Q4 		$96.3K Hold
14,262
– – ﹤0.01% 41
2023
Q3 		$63.3K Hold
14,262
– – ﹤0.01% 43
2023
Q2 		$47.1K Hold
14,262
– – ﹤0.01% 46
2023
Q1 		$40.6K Sell
14,262
-241,190
-94% -$2.16M ﹤0.01% 49
2022
Q4 		$1.86M Hold
255,452
– – 0.11% 34
2022
Q3 		$2.07M Hold
255,452
– – 0.11% 38
2022
Q2 		$1.25M Hold
255,452
– – 0.07% 45
2022
Q1 		$6.04M Hold
255,452
– – 0.2% 38
2021
Q4 		$4.52M Hold
255,452
– – 0.11% 44
2021
Q3 		$7.21M Sell
255,452
-422,689
-62% -$8.01M 0.17% 33
2021
Q2 		$7.11M Hold
678,141
– – 0.14% 28
2021
Q1 		$7.99M Hold
678,141
– – 0.32% 24
2020
Q4 		$7.94M Hold
678,141
– – 0.38% 23
2020
Q3 		$5.38M Sell
678,141
-4,099
-0.6% -$49.4K 0.25% 18
2020
Q2 		$12.5M Sell
682,240
-43,949
-6% -$692K 0.58% 12
2020
Q1 		$8.67M Buy
726,189
+11,904
+2% +$190K 0.57% 14
2019
Q4 		$11.9M Hold
714,285
– – 0.72% 12
2019
Q3 		$4.74M Buy
+714,285
New +$7.9M 0.14% 19

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Alphabet Inc's FULC Position: Q1 2026 in Review

Alphabet Inc sold out of Fulcrum Therapeutics (FULC) in Q1 2026, closing a stake of 14,262 shares — an estimated $161K sold.

Alphabet Inc first reported a position in FULC in Q3 2019 and held it in 26 quarters. The position peaked at $12.5M in Q2 2020. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Alphabet Inc reported no remaining Fulcrum Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Alphabet Inc sold 14,262 Fulcrum Therapeutics shares in Q1 2026, an estimated $161K.
  • Alphabet Inc first reported a position in Fulcrum Therapeutics in Q3 2019 and held it in 26 quarters.
  • Alphabet Inc's Fulcrum Therapeutics position peaked at $12.5M in Q2 2020.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Alphabet Inc's 13F filing for Q1 2026, filed 8 May 2026.